Join OurCrowd Founder & CEO, Jon Medved, for a cocktail reception and fireside chat celebrating Jerusalem’s booming tech scene with Jerusalem Mayor Moshe Lion.
The event will feature presentations from the founders of BrainQ and Intuition Robotics – all disrupting their respective industries. We look forward to bringing together community leaders, investors, and entrepreneurs to meet the OurCrowd team and our startups.
This venue is across the street from the Convention Center.
Jonathan Medved is a serial entrepreneur and according to the Washington Post (2007) “one of Israel’s leading high-tech venture capitalists”. In the 2008 NY Times Supplement “Israel at 60” Medved was named one of the top 10 most influential Americans who have impacted Israel.
Medved is the founder and CEO of OurCrowd, the world’s largest equity crowdfunding platform for accredited investors which has raised more than $1B for almost 180 companies since its launch in February 2013. Bloomberg Businessweek said that OurCrowd “has blown up the exclusivity around tech fundraising” and The Jerusalem Post added that “It has taken OurCrowd only a matter of months to become one of Israel’s most active funds”. TheStreet.com said that OurCrowd is “Crowdfunding for Real Investors.”
Prior to OurCrowd, Medved was the co-founder and CEO of Vringo (Nasdaq:VRNG) and the co-founder and General Partner of Israel Seed Partners, with $262M under management.
Impact Investing: Making Money While Doing Good
OurCrowd Investor Breakfast*
Join us for an event featuring the OurCrowd Impact Fund, in partnership with Social Finance Israel, a leading impact advisory firm founded by the godfather of impact investing, Sir Ronald Cohen. In addition, BrainQ will share its mission to help patients following neuro-disorder back on their feet, Surgical Theater will present its 3D imaging software for planning and rehearsing complex surgeries, MedAware will describe its impact combating the opioid crisis, and Intuition Robotics will demo their intelligent companion robots for the elderly.
Tuesday, March 26th
Crowell & Moring LLP
1001 Pennsylvania Avenue, NW
*Please note that this event is for accredited investors only.
OurCrowd is the leading global equity crowdfunding platform for accredited investors. Managed by a team of seasoned investment professionals and led by serial entrepreneur Jon Medved, OurCrowd vets and selects opportunities, invests its own capital, and brings companies to its accredited membership of global investors. OurCrowd provides post-investment support to its portfolio companies, assigns industry experts as mentors, and takes board seats. The OurCrowd community consists of almost 30,000 accredited investors from over 150 countries. OurCrowd has raised over $900M and invested in 170 portfolio companies and funds.
BrainQ’s mission is to help get patients following neuro disorder, ‘back on their feet’ again, using AI. BrainQ’s multi-patented medical device, BQ 1.0, uses state-of-the-art Machine Learning algorithms to identify high resolution spectral patterns in patient’s brain waves and translate them into a non-invasive, frequency-dependent, low intensity electromagnetic treatment that facilitates neuro-connectivity and enhances recovery.
MedAware develops machine learning-enabled decision support and patient safety solutions. The first application of this technology utilizes big data analytics and advanced machine learning algorithms to detect medication errors, evolving adverse drug events (ADEs), and patient-specific risk of opioid dependency with unprecedented accuracy. As a result of its efficacy, in live clinical settings, providers heed MedAware’s warnings, often altering their prescription and care plan recommendations. This level of success and clinical relevance is achieved through the use of advanced machine-learning capabilities and clinical relevant data. Moving away from the limiting, rule-based technologies on the market today and utilizing true AI capabilities, MedAware flags outliers and potentially life-threatening prescriptions which conflict with the profile of the patient, physician, or institution.
Intuition Robotics is a disruptive artificial intelligence (AI) company that is redefining the relationship between humans and machines. The company’s cognitive AI technology platform, ‘Q’, enables devices to become context-aware, proactive, personalized, and adaptive. Intuition Robotics’ first product is ElliQ, an award-winning social robot for older adults that encourages an active and engaged lifestyle.
Surgical Theater has developed an innovative 360-degree, 3D immersive virtual reality platform for enhancing operating room workflows and pre-operative planning, as well as for patient engagement and medical education purposes. Surgical Theater’s solution combines the science of flight simulation with advanced CT and MRI imaging technology; it enables both doctor and patient to enter a virtual reality reconstruction of the patient’s anatomy and facilitates patient-specific planning, surgical efficiency during procedures such as brain surgery and patient comfort with the prescribed treatment.
Bernstein, a global equity research firm based in New York, is featuring OurCrowd’s portfolio of Israeli startups including BioCatch, Consumer Physics, ThetaRay, and more, at their “Investing in Israel: A Day with Entrepreneurs and Insiders,” Israeli Tech Conference scheduled to take place on Tuesday, April 2nd in New York.
The conference will include a mix of fireside chats, panels and industry speakers. Mark Moerdler, Bernstein’s Senior Analyst covering Global Software will be the lead analyst hosting this event.
Mark Moerdler is the Senior Analyst at Bernstein covering Global Software. Prior to joining Bernstein in 2010, Mark was Vice President of Strategy for Mergers and Acquisitions at CA Technologies. He joined CA in June 2006 as Vice President of Business Unit Strategy, when the company he co-founded, MDY Advanced Technologies, was acquired by CA. At the time, MDY was the leader in Records Management software, according to both Gartner and Forrester Research. Mark received two Master’s degrees and a PhD in Computer Science from Columbia University. Mark has been named to Institutional Investor’s All-America Research Team since 2013; in 2017, he was the No. 1-ranked analyst in the Software sector.
For more information, please email Shulamit.email@example.com
Join investors from around the world for a morning of innovation & tech in the startup capital
This Passover holiday, engage with up-and-coming startups, portfolio companies, and investment opportunities while enjoying breakfast and networking. Experience the latest tech demos and meet peers from the global OurCrowd community, in the heart of the Startup Nation.
We hope to see you in Jerusalem!
Note: This event is limited to accredited investors only. If you would like to invite a guest, they must visit the OurCrowd website and, if they meet the criteria, click Join to register as an accredited investor.